Cytokinetics Inc
F:KK3A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Cytokinetics Inc
F:KK3A
|
US |
|
D
|
Dear U Co Ltd
KOSDAQ:376300
|
KR |
|
E
|
Expeditors International of Washington Inc
XMUN:EW1
|
US |
|
Teleperformance SE
F:RCF0
|
FR |
|
Hill and Smith PLC
OTC:HSHPF
|
UK |
|
F
|
Forcs Co Ltd
KOSDAQ:189690
|
KR |
|
K
|
KCC Engineering & Construction Co Ltd
KOSDAQ:021320
|
KR |
|
Indo Kordsa Tbk PT
IDX:BRAM
|
ID |
|
C
|
CDW Corp
DUS:CDW
|
US |
|
R
|
Recordati Industria Chimica e Farmaceutica SpA
SWB:RER1
|
IT |
|
Golden Flower Tbk PT
IDX:POLU
|
ID |
|
C
|
Central China Securities Co Ltd
SWB:21C
|
CN |
|
A
|
ANI Pharmaceuticals Inc
F:BSFA
|
US |
|
D
|
DuoBack Co Ltd
KOSDAQ:073190
|
KR |
|
P
|
Principal Financial Group Inc
F:PG4
|
US |
Bankruptcy Probability
Cytokinetics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Cytokinetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Cytokinetics Inc
NASDAQ:CYTK
|
8.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
510.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
251.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
211.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
140.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
99.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
88.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
49B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
54.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Cytokinetics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Cytokinetics Inc has total debt of 1.1B USD. This includes both short-term (0 USD) and long-term (1.1B USD) debt.
You can find a full breakdown on its Balance Sheet.
